2019 Pompe Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

April 2019 | 61 pages | ID: 279BF4C1888EN
VPAResearch

Abstracts

The global clinical trial report- “2019 Pompe Disease Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pompe Disease. It presents in-depth analysis of Pompe Disease clinical trials across markets and companies. The research work is for providing complete understanding into trends in Pompe Disease.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Pompe Disease clinical trials by-

• Current Trial Status
• Type of the trial
• Sponsor Type
• Enrollment Trends
• Region
• Countries
• Trial Phase

The report also identifies the potential drug candidates under development for treatment of Pompe Disease

The research work is prepared through extensive and continuous research on Pompe Disease trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:

• All major trials from 2010 to 2019 and planned trials are included in the report scope.
• Drug candidates currently being researched for administering Pompe Disease patients are identified
• The report includes panorama of Pompe Disease clinical trials across the globe
• Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
• Companies and universities focusing on Pompe Disease clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
• Average Enrollment number, insights into enrollment trends, company wise enrollment are included
• Both interventional and observational studies are analyzed
• News and latest developments for the past one year are presented in the report

Contents

1. TABLE OF CONTENTS

1.1 List of Figures
1.2 List of Tables

2. EXECUTIVE SUMMARY

2.1 Pompe Disease Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
  2.2.1 Pompe Disease Clinical Trials by Region
  2.2.2 Average Enrollment of Pompe Disease Clinical Trials
  2.2.3 Companies participating in Trials
  2.2.4 Drugs under Study for Pompe Disease Treatment, 2019

3. REGION WISE POMPE DISEASE CLINICAL TRIALS

3.1 Asia Pacific Pompe Disease Clinical Trials by Country
3.2 Europe Pompe Disease Clinical Trials by Country
3.3 North America Pompe Disease Clinical Trials by Country
3.4 Middle East and Africa Pompe Disease Clinical Trials by Country
3.5 South and Central America Pompe Disease Clinical Trials by Country

4. POMPE DISEASE CLINICAL TRIAL TRENDS

4.1 Start Year wise Pompe Disease Clinical Trials
4.2 Phase wise Pompe Disease Clinical Trials
4.3 Trial Status wise Pompe Disease Clinical Trials
4.4 Trial Type wise Pompe Disease Clinical Trials

5. POMPE DISEASE AVERAGE ENROLLMENT TRENDS

5.1 Average Enrollment in Pompe Disease Trials by Year
5.2 Average Enrollment in Pompe Disease Trials by Phase
5.3 Average Enrollment in Pompe Disease Trials by Status
5.4 Average Enrollment in Pompe Disease Trials by Type of Trial

6. COMPANIES PARTICIPATING IN POMPE DISEASE CLINICAL TRIALS

6.1 Pompe Disease Trials by Sponsor Type
6.2 Pompe Disease Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS

7.1 Pompe Disease Trials- Phase
7.2 Pompe Disease Trials- Phase
7.3 Pompe Disease Trials- Phase
7.4 Pompe Disease Trials- Phase

8. APPENDIX

8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List Of Figures

LIST OF FIGURES

Figure 1: Pompe Disease Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Pompe Disease Clinical Trials and Enrolment
Figure 5: Europe – Country wise Pompe Disease Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Pompe Disease Clinical Trials and Enrolment
Figure 7: North America – Country wise Pompe Disease Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Pompe Disease Clinical Trials and Enrolment
Figure 9: Pompe Disease Clinical Trials by Phase
Figure 10: Pompe Disease Clinical Trials by Trial Status
Figure 11: Pompe Disease Clinical Trials by Type
Figure 12: Pompe Disease Clinical Trials by Sponsor Type
Figure 13: Pompe Disease Clinical Trials by Leading Sponsors
Figure 14: Pompe Disease Average Enrollment by Phase
Figure 15: Pompe Disease Average Enrollment by Trial Status
Figure 16: Pompe Disease Average Enrollment by Type
Figure 17: Pompe Disease- Average Enrolment by Type of Sponsors
Figure 18: Pompe Disease- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology

List Of Tables

LIST OF TABLES

Table 1: Pompe Disease Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Pompe Disease Clinical Trials and Enrolment
Table 5: Europe – Country wise Pompe Disease Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Pompe Disease Clinical Trials and Enrolment
Table 7: North America – Country wise Pompe Disease Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Pompe Disease Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Pompe Disease Average Enrollment by Phase
Table 15: Pompe Disease Average Enrollment by Trial Status
Table 16: Pompe Disease Average Enrollment by Type
Table 17: Pompe Disease- Average Enrolment by Type of Sponsors
Table 18: Pompe Disease- Enrolment by Leading Sponsors